Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;195(4):532-535.
doi: 10.1111/bjh.17740. Epub 2021 Sep 14.

The real impact of COVID-19 on an East London Sickle cell population: results of a service-wide survey

Rhys Hall  1 , John Meenan  1 , Diana Mihalca  1 , Alvin Katumba  1 , Saket Badle  1 , Dede-Kossi Osakonor  1 , Oloruntoyin Bello-Sanyaolu  1 , Funmilayo Orebayo  1 , Natasha Lewis  1 , Basabi Chatterjee  1 , Stephanie Coughlin  2 , Dimitris A Tsitsikas  1
Affiliations

The real impact of COVID-19 on an East London Sickle cell population: results of a service-wide survey

Rhys Hall et al. Br J Haematol. 2021 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None to declare.

Figures

Fig 1
Fig 1
Distribution of answers according to genotype (A), age (B) and gender (C). Vaccination Y/NY, vaccinated already/keen to be vaccinated but not yet received first dose; Vaccination U, uncertain whether to be vaccinated; Vaccination DW, does not want to be vaccinated.
See this image and copyright information in PMC

References

    1. Arlet JB, de Luna G, Khimoud D, Odièvre MH, de Montalembert M, Joseph L, et al. Prognosis of patients with sickle cell disease and COVID‐19: a French experience. Lancet Haematol. 2020;7:e632–4. - PMC - PubMed
    1. Panepinto JA, Brandow A, Mucalo L, Yusuf F, Singh A, Taylor B, et al. Coronavirus disease among persons with sickle cell disease, United States, March 20‐May 21, 2020. Emerg Infect Dis. 2020;26:2473–6. - PMC - PubMed
    1. Telfer P, De la Fuente J, Sohal M, Brown R, Eleftheriou P, Roy N, et al. Real‐time national survey of COVID‐19 in hemoglobinopathy and rare inherited anemia patients. Haematologica. 2020;105:2651–4. - PMC - PubMed
    1. Minniti CP, Zaidi AU, Nouraie M, Manwani D, Crouch GD, Crouch AS, et al. Clinical predictors of poor outcomes in patients with sickle cell disease and COVID‐19 infection. Blood Adv. 2021;5:207–15. - PMC - PubMed
    1. McCloskey KA, Meenan J, Hall R, Tsitsikas DA. COVID‐19 infection and sickle cell disease: a UK centre experience. Br J Haematol. 2020;190:e57–e58. - PubMed

MeSH terms

Substances